ÎÚÑ»´«Ã½

Jennifer R. Brown, MD, PhD, is director of the Chronic Lymphocytic Leukemia (CLL) Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and the Worthington and Margaret Collette Professor of Medicine in the field of Hematologic Oncology at Harvard Medical School. Her research interests include the development of novel targeted therapies for CLL and CLL genomics.

Dr. Brown has been an ASH member since 2003 and previously served as chair of the Committee on ÎÚÑ»´«Ã½al Affairs, liaison to the Publications Committee, and joint Program Committees. Her service as chair was preceded in other roles, including ÎÚÑ»´«Ã½ Program Advisory Panel member, abstract reviewer, Clinical Research Training Institute faculty, and study section reviewer.